Sort by
Refine Your Search
-
Category
-
Country
-
Field
-
vivo perturbational screening. We have developed single-cell CRISPR technologies that enable dozens of molecular factors to be screened in vivo during development and disease, accelerating the
-
perturbational screening. We have developed single-cell CRISPR technologies that enable dozens of molecular factors to be screened in vivo during development and disease, accelerating the discovery
-
development, networking, and mentorship. A highly stimulating and supporting international research environment. Start date: as soon as possible. How to apply? Interested candidates can apply through the
-
in kinase inhibitor development, many regulatory mechanisms remain poorly understood, particularly those involving allosteric and non-catalytic interfaces. As a member of the ANA-KIN Doctoral Network
-
targets in modern medicine. Despite major advances in kinase inhibitor development, many regulatory mechanisms remain poorly understood, particularly those involving allosteric and non-catalytic
-
targets in modern medicine. Despite major advances in kinase inhibitor development, many regulatory mechanisms remain poorly understood, particularly those involving allosteric and non-catalytic